Marquette University

e-Publications@Marquette
School of Dentistry Faculty Research and
Publications

Dentistry, School of

6-2016

Three-Dimensional Bioprinting Materials with Potential
Application in Preprosthetic Surgery
Mina D. Fahmy
Marquette University

Hossein E. Jazayeri
Marquette University

Mehdi Razavi
Brunel University

Radi Masri
University of Maryland at Baltimore

Lobat Tayebi
Marquette University, lobat.tayebi@marquette.edu

Follow this and additional works at: https://epublications.marquette.edu/dentistry_fac
Part of the Dentistry Commons

Recommended Citation
Fahmy, Mina D.; Jazayeri, Hossein E.; Razavi, Mehdi; Masri, Radi; and Tayebi, Lobat, "Three-Dimensional
Bioprinting Materials with Potential Application in Preprosthetic Surgery" (2016). School of Dentistry
Faculty Research and Publications. 184.
https://epublications.marquette.edu/dentistry_fac/184

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Three-Dimensional Bioprinting
Materials with Potential Application
in Preprosthetic Surgery

Mina D. Fahmy
School of Dentistry, Department of Developmental Sciences,
Marquette University,
Milwaukee, WI

Hossein E. Jazayeri
School of Dentistry, Department of Developmental Sciences,
Marquette University,
Milwaukee, WI
School of Dental Medicine, University of Pennsylvania,
Philadelphia, PA

Mehdi Razavi
BCAST, Institute of Materials and Manufacturing,
Brunel University London,
Uxbridge, London, UK.
Brunel Institute for Bioengineering, Brunel University London,
Uxbridge, London, UK

Journal of Prosthodontics, Vol 25, No. 4 (June 2016): pg. 310-318. DOI. This article is © Wiley and permission has been
granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to be
further copied/distributed or hosted elsewhere without the express permission from Wiley.

1

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Radi Masri
Department of Endodontics, Prosthodontics and Operative
Dentistry, University of Maryland School of Dentistry,
Baltimore, MD

Lobat Tayebi
School of Dentistry, Department of Developmental Sciences,
Marquette University,
Milwaukee, WI
Department of Engineering Science, University of Oxford,
Oxford, UK

We acknowledge the grant from Marquette strategic Innovation fund (3D
Printing of Customized Implants for Cleft Lip, Palate and Orofacial
Deformities and Defects).
Supported in part by the National Science Foundation (NSF, Grant no.CMMI1363485) and Marquette University Strategic Innovation Fund.
The authors deny any conflicts of interest.
Abstract: Current methods in handling maxillofacial defects are not robust
and are highly dependent on the surgeon's skills and the inherent potential in
the patients’ bodies for regenerating lost tissues. Employing custom-designed
3D printed scaffolds that securely and effectively reconstruct the defects by
using tissue engineering and regenerative medicine techniques can
revolutionize preprosthetic surgeries. Various polymers, ceramics, natural and
synthetic bioplastics, proteins, biomolecules, living cells, and growth factors
as well as their hybrid structures can be used in 3D printing of scaffolds,
which are still under development by scientists. These scaffolds not only are
beneficial due to their patient-specific design, but also may be able to prevent
micromobility, make tension free soft tissue closure, and improve vascularity.
In this manuscript, a review of materials employed in 3D bioprinting including
bioceramics, biopolymers, composites, and metals is conducted. A discussion
of the relevance of 3D bioprinting using these materials for craniofacial
interventions is included as well as their potential to create analogs to
craniofacial tissues, their benefits, limitations, and their application.

Three-dimensional (3D) printing, or additive manufacturing
(AM), was first used by Charles Hull in 1986 to sequentially form a 3D
structure using layered light-cured material.1 Initially, 3D printing was
not used for biological applications but was employed for the
deposition of metals and ceramics, which was not conducive to living
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cells. Thus, a challenge with 3D bioprinting is finding suitable
biocompatible materials while also providing the mechanical and
functional properties for maintaining the tissue.2 Three-dimensional
bioprinting is a relatively new and emerging field in which advances
have led to the printing of biocompatible materials for the production
of medical devices as well as the replacement of human tissues and
organs.3,4 During 3D bioprinting, biological materials and reagents are
placed in precise cross-sectional layers from the bottom.2,5,6 The
process begins with a 3D model, which is created by a computer-aided
design (CAD) software. Cross-sectional slices are then taken of the
model and sent to the AM device, which ultimately deposits each layer
to produce the object.5 Compared to conventional techniques in which
several parts are assembled, in 3D bioprinting the final product can be
produced in a single process, leading to a reduction in time and cost.
In addition, design files may be transferred electronically and retained
indefinitely, unlike conventional technology where designs are difficult
to share and physical prototypes occupy space.5 Furthermore, 3D
printing provides more efficient use of raw materials and limits the
amount of needed energy for the production process.5
There are numerous approaches to a 3D bioprinting process,
including cell types, printing techniques, and materials selection. As
noted by Murphy and Atala, materials must have appropriate
crosslinking mechanisms to allow for proper deposition and
biocompatibility over the long term.2 In addition, it is imperative that
materials support the proliferation of cells, as well as cellular function
and attachment.7 Although the future of this profound and expanding
technology is uncertain, it is expected to revolutionize the
manufacturing industry, in turn benefiting numerous fields, including
the medical and dental realm.
In this review, different commonly used biomaterials in 3D
printing are explored, along with a discussion of their advantages and
disadvantages. The applications of 3D bioprinting in dentoalveolar
repair due to maxillofacial injury, disease, pathology, or trauma are
also discussed in conjunction with the use of scaffolds.
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Clinical applications
Three-dimensional bioprinting using CAD data for the creation of
a model has been used in numerous areas of medicine. As noted by
Vorndran et al, AM has the advantage of allowing for the fabrication of
biologic implants from computer tomography (CT) data specific to the
patient.8 Autografts and allografts have been used in reconstructive
surgery to treat several craniofacial anomalies and abnormalities.9
Although autografting is considered the gold standard because graft
material contains live cells and growth factors, this process can be
highly invasive and may cause donor site morbidity as well as
extended hospital stays.10,11 Allografts are not invasive to the patient,
but there are several ethical concerns as well as concerns regarding
contamination.12 Common to both procedures is that the graft must be
manually shaped to precisely fit the defect during surgery, possibly
leading to inaccuracies and lack of superior esthetics.13 Threedimensional bioprinting technology allows for the fabrication of
artificial grafts that may be superior to both autografts and allografts
in adaptation, safety, and invasiveness.14 Desired characteristics of 3D
printed biomaterials include biocompatibility and osteoconductivity.15
Porosity is also an important factor to allow for tissue in-growth, vessel
formation, and conveyance of nutrition to the newly produced
tissues.16-18 Moreover, customizability of shape, size, orientation, and
pore connectivity is vital to ensure that the envelope of soft tissue
covering the affected bone is esthetically acceptable, while still
allowing for the scaffold to restore initial functionality.15,19
Due to congenital abnormalities, cancerous growths, and
traumatic injuries, the management of tissue loss has been a topic of
study in the surgical realm. Several materials, including bioceramics,
biopolymers, composites, and metals, have been reported in the
literature and may be used to make customized 3D scaffolds for use in
dentoalveolar defect repair. These materials will be discussed and
reviewed in the following sections.

Materials used for 3D bioprinting
Bioceramics
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Calcium phosphate
Calcium phosphate compounds have been used because of their
ability to chemically bond to hard tissue.20 Tricalcium phosphate (TCP)
exists as three polymorphs, including the less dense but more soluble
monoclinic α and hexagonal α′, and the higher density, rhombohedral
β form.21 The α and α′ forms are formed at high temperatures and can
be converted from the β state between 1100 and 1200°C, whereas a
conversion from β to α involves slow cooling.22 TCP ceramics have
been shown to exhibit more biodegradability than other material
candidates including hydroxyapatite (HA).23 Lacefield has found that
bone formation is aided by the release of Ca and PO4 ions near the
implant.24 Klein et al noted that in comparison to HA coatings, α-TCP
induced greater amounts of bone remodeling within the first week of
implantation.25 TCP materials slowly resorb in physiological conditions
and may be molded into the defects in granule form; however, these
granules can only be placed into the defects surrounded by intact
bone. Conversely, calcium phosphate cements (CPC) can be molded
freely and will provide necessary mechanical soft tissue support after
hardening. Despite this advantage, the use of CPC is limited due to
lack of macroporosity. Custom-made calcium phosphate implants with
a defined structure for precise patient fitting have been designed to
circumvent the issue of lack of macroporosity.26 β-TCP is the most
favorable form of TCP due to its mechanical strength and chemical
stability, although there are several challenges associated with it
including maintaining a low sintering temperature so as to avoid a
transformation to α-TCP.27 Miranda et al note that β-TCP scaffolds
containing a 3D network of rods have been designed by direct-write
assembly, while optimization of β-TCP printing materials has been
investigated.28

Hydroxyapatite
Because of the stoichiometric similarity to the mineral phase of
natural bone, HA has been deemed a bone replacement with good
potential for biocompatibility.29,30 HA implants have been assembled by
means of numerous techniques, including hydrothermal conversion,31
use of polymer sponges,32 and bulk ceramic processing techniques.33
However, all of these methods are limited in ability to control the
implant's porosity. Several methods have been recently developed to
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allow for the controlled design and engineering of 3D HA scaffolds. The
stereolithography (SLS) technique has been used to build HA scaffolds
using the lost-mold technique.34 In addition, direct-write assembly
using colloidal inks with tailored viscoelastic properties was also used
for the construction of 3D HA scaffolds.35,36 Michna et al have
developed HA scaffolds with the desired characteristics by customizing
their architecture and sintering conditions using HA printing material
suitable for direct-write assembly.37 Chumnanklang et al described
how adhesive binder could be incorporated by means of two methods
in the preparation of HA powder: either mixing as separate grains or
coating the HA powder.38 Leukers et al used HA granules to create
ceramic porous constructions. A patient's own cells may be seeded
onto the scaffold for tissue engineering. Leukers et al noted that the
produced scaffolds can act as 3D templates for primary cell
attachment, which is followed by tissue formation.39 Irsen et al
emphasized that HA granulates may not fulfill all of the necessary
requirements for use in 3D printing because HA is expensive, and does
not optimally interact with binder liquid. Optimization of bioprinting
techniques is required to attain good surface quality in addition to
achieving better resolution.40

Bioglass
Bioactive glasses (BG) have shown great potential in both the
healing and regeneration of bone defects because of their ability to
support osteoblast cells, and to bond to both soft and hard tissue.41,42
BG is an attractive alternative for other scaffold materials because of
its ability to stimulate angiogenesis in the presence of vascular
endothelial growth factor (VEGF).43 BG displays characteristics of
osteoconductivity and oseteoproductivity; both are features that
improve the proliferation and differentiation of progenitor cells.44 An
important feature of BG is development of a biologically active surface
layer of HA and carbonated hydroxyapatite (CHA) allowing for
interfacial bonding to surrounding tissues without scar layer
formation.45,46 However, BG does not usually degrade at a quick
enough rate and thus may remain within the body for an extended
time.47 A concern with using porous BG scaffolds is their cytotoxicity
on the surrounding environment, perhaps caused by high ion
concentration.48
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The advantage of using ceramics such as HA, bioglass, and
calcium phosphate is that they can upregulate osteogenesis. Another
advantage is their ability to allow for space maintenance, making them
materials of interest in reconstruction of craniofacial defects.49
Bioceramic-printed scaffolds allow for rapid population of the cells onto
the scaffold surface as well as promoting the proliferation of cells;
however, ceramics are too brittle to allow for implantation in loadbearing craniofacial sites (i.e., implants designed to restore or replace
the temporomandibular joint [TMJ]).50

Biopolymers
Alginate
Alginate is a water-soluble polysaccharide with properties similar
to the native extracellular matrix, so it is effective in tissueengineering applications. Alginate has profound implications on
cartilage repair as a potent hydrogel, and it is widely understood that
alginate is extremely compatible with cartilaginous tissue.51,52 Cell
encapsulation of alginate in biomedical applications has proven to be
effective due to its support of surrounding chondrocytes.53
Furthermore, alginate induces chondrocyte proliferation.52 The
morphology of chondrocytes becomes more easily rounded by the
material, and the mechanical properties of alginate continue to make it
a desirable substance in tissue regeneration.54 Alginate gel has the
capacity to allow for surrounding tissue resistance upon implantation
until precursor stem cells migrate to the area and differentiate into
chondrocytes.55
Additionally, 3D alginate constructs have been frequently used
to induce differentiation of human mesenchymal stem cells for
fibrocartilage repair and for their ability to induce cell expansion.
Alginate is much more effective when combined with another
compound, such as chitosan or polylactide, because of its mechanical
vulnerability and degradability by rapid ion exchange.56 Alginate can
be molded and injected, and these properties also make it an
attractive candidate for TMJ cartilage engineering applications.57,58 The
hydrophilic characteristics of alginate enhance its biocompatibility, and
it promotes osteocyte growth and works synergistically with growth
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factors, such as vascular endothelial growth factor (VEGF), to repair
defected bone.59
A limitation of alginate is that it frequently does not interact
with cells and proteins. As stated above, it is necessary for alginate to
be combined in a scaffold with another compound that increases its
cell attachment capabilities to optimize regeneration of the tissue.60
Although hydrogels, like alginate, generally promote regeneration,
they are not suitable for load-bearing applications.59 Hydrogels have
been said to have the ability of exposing cells to environments that are
very hydrated and resemble natural ECM; however, hydrogels also
present with a very low stiffness characteristic relative to most loadbearing tissues in the maxillofacial region.50 Thus, printing scaffolds for
the regeneration of tissues required to sustain higher mechanical
forces for craniofacial defects requires the use of other materials,
including ceramics or composites.61

Biogenic polyphosphate
Biogenic polyphosphates (bio-polyP) have been used to create
porous scaffolds for tissue engineering. They have been studied
frequently for their prominence in scaffold implantation because of
their reputable biocompatibility.62 Bioprinted bio-polyP scaffolds have
remarkable resolution, and their immediate fabrication requires no
further processing, unlike other methods.63 Bio-polyP not only
increases the release of bone morphogenetic protein 2 and accelerates
bone mineralization, but also inhibits the differentiation of osteoclastic
precursors into osteoclasts, preserving the integrity of bone and
preventing resorption.64 Moreover, the expression of osteocalcin and
osterix, proteins involved in osteoblast differentiation, is increased.65
The purpose of using bio-polyP is to stimulate the inductive role of the
native, healthy extracellular matrix present prior to the onset of
disease or trauma.66 Bio-polyP is an ideal polymer for use in scaffolds
for bone regeneration because it can be hardened after printing. Its
inductive activity makes it favorable as it stimulates osteocytes to
undergo an anabolic process that results in HA formation.64 The
influence of polyphosphate on bone repair is profound, because it
regulates scaffold porosity and increases its osteoconductivity.67 Newly
formed natural bone can then grow within the scaffold.68 The ideal
matrix environment can be mimicked by the polymer's vast
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morphogenetic capabilities. Moreover, bio-polyP can play a role in
regulating organismic hemostasis, affecting the body's coagulation
cascade.69 Precisely fitting, patient-specific scaffolds can be designed
with these types of materials to ensure a cost-effective and lasting
treatment solution.15 It remains unknown in which form bio-polyP
stimulates bone mineralization, in a polymeric state or monomeric
phosphates resulting from hydrolytic breakdown.64 Craniomaxillofacial
(CMF) bone defects, with the aid of CAD/CAM software, can be
repaired with bio-polyP, among many other biocompatible materials, in
scaffold fabrication and implantation.70

Biogenic silica
Biogenic silica (BSi) shares very similar properties and invokes
nearly identical biochemical action to bio-polyP. Both materials are
morphogenetically active and are incredibly resistant to non-favorable
environmental conditions.71 The complex architecture of a BSi network
and its strong opto-mechanical properties allow it to be exceptionally
potent in nanomedicine and bone repair.72 The porosity of the scaffold
influenced by the use of BSi allows for effective nutrient diffusion,
which is essential for much of the avascular hard tissue composing the
majority of the craniofacial skeleton. BSi is routinely used in
nanoparticle form and has recently been applied to bone regeneration
studies.73 The use of the mentioned nanomaterials significantly
increases the expression of collagen type I.74 BSi has proven to be
effective by stimulating the mineralization of SaOS-2 cell line, a type
of cell similar to osteoblasts, in vitro. It also regulates the
concentration of osteoprotegerin, which plays a role in bone
resorption.75 The printing of cells into a scaffold has not yet made
great strides, but the demonstration of an alginate scaffold complex
containing osteoblasts has been effective in allowing those bone cells
to proliferate only if BSi is added to induce the process.65 The ability of
BSi to be absolutely essential in the mineralization of hard tissue
makes it a quality candidate for printing applications, especially in
maxillofacial trauma cases.76 Its trabecular architecture is favorably
shaped by silica to allow for optimal biocompatibility.77 Immersing the
material in a layer of body fluid forms a layer similar to maxillofacial
hard tissue, and its variation in pore size makes it very applicable for
drug delivery systems and tissue-engineering cases.78 Its high surface
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charge density attracts proteins to its surface and has been thought to
positively affect cell adhesion to the scaffold complex.79
Furthermore, it is beneficial that BSi does not disrupt calcium
concentration or pH levels.80 The pore size of the silica-based scaffold
affects the rate of nucleation as well, enhancing the bioactivity of the
material. There was no mention of disadvantages in using biogenic
silica for scaffold preparation and delivery to treat bone defects; it is
very suitable for hard-tissue engineering.64 Prosthetic applications and
microsphere drug conveyance benefit from the research of silica
properties and overall effect, while researchers deduce that it holds
great promise in nanomedicine applications.81

Composites
A number of biopolymers have been considered for bone tissue
engineering applications; however, no sole polymer is able to satisfy
all the necessities for a bone graft material. To overcome the problems
involving individual materials, composite materials have been recently
developed, given that natural bone is an organic/inorganic hybrid
composed of collagen and apatites.6,82 Polymer/ceramic composites
contain the appropriate properties of each individual component,
including the high wear resistance of ceramics and high toughness of
polymers. This knowledge also allows for manufacturing of biphasic
porous scaffolds to regenerate damaged tissues such as the TMJ.83

Calcium phosphate/collagen
3D bioprinting under low temperatures allows for the production
of composites with synthetic or natural polymers such as collagen.
Adding collagen into mineralized bone cements could improve their
mechanical characteristics in addition to their bioactive properties.83
Inzana et al83 assessed the possibility of using low-temperature
3D bioprinting for production of collagen-calcium phosphate composite
by dissolving collagen into phosphoric acid as a binder solution. Highresolution inkjet printing of collagen has not been previously used in
3D printing of calcium phosphates. This research showed the
possibility of using high-resolution inkjet printing of collagen in 3D
printing of calcium phosphates and its effect on the mechanical and
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cellular characteristics of collagen inclusion in vitro. Adding collagen
into the phosphoric acid binder solution notably enhanced the strength
of the 3D printed calcium phosphate as a linear function of collagen
concentration. In vitro cell culture experiments confirmed the viability
of C3H/10T1/2 cells cultured on the scaffold materials for about 72
hours. In comparison to previous studies on printing collagen for
production of a fibrous network,84 in this research the viscous solution
of collagen was printed by a DC solenoid inkjet valve with a larger
diameter. Moreover, in vivo studies showed that the 3D printed
scaffolds encouraged new bone growth into the pores as they were
degraded and integrated into the newly forming bone.83

Hydroxyapatite/polyamide
HA may not have adequate properties to mimic the composition,
structure, and properties of natural bone.85 Incorporation of polyamide
presents improved mechanical properties, since it is similar to the
chemical structure of bone collagen and shows outstanding mechanical
properties.86
In a previous study, a nanocomposite of HA and polyamide and
CAD/CAM was used in the treatment of maxillofacial defects.85 Using
CT and AM, a perfect-fitting condylar implant from biomimetic nano
HA/polyamide scaffold was fabricated for a patient who suffered from
mandibular angle reduction with malocclusion, deviated mouth,
collapse of the right side of the face, and masticatory problems. The
patient finally recovered good jaw contour, appearance, and TMJ
function. The report recommended that CAD/CAM and RP nano
HA/polyamide implants may be a practical option compared to the gold
standard autografts for maxillofacial defects.85

Cell-hydrogel
AM techniques in cell-based tissue engineering have resulted in
the development of a new model, called organ or tissue printing,
wherein hydrogel matrices and cells are spatially arranged into layered
hybrid structures, with organized architecture and defined cellular
placement.87 Development of cell-seeded implants that mimic native
tissues considering anatomical specific shape, spatial configuration,
and the cell's environment may finally speed up and enhance the
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functionality of tissue-engineered scaffolds.87 Fedorovich et al
characterized layered 3D fiber deposition of osteoprogenitor cells in
hydrogels to use the concept of organ or tissue printing for making
vascularized bone grafts.87 For this purpose, a Bioplotter pneumatic
dispensing system was employed for fiber deposition, and the cellhydrogel composites were placed into a syringe and loaded into the
bioplotter to produce four-layer constructs. The results showed that
embedded cells were homogeneously dispersed inside the deposited
hydrogel scaffolds, and the cells remained intact after the deposition.87
Although the results of other research groups reported
decreased cell viability at similar deposition pressures of printing
process, the results of this study confirmed that the printing process
does not negatively influence the viability of cells.88 This suggests that
the 3D fiber deposition approach can be used for bone tissue printing
and indicates potential for the development of vascularized bone
grafts.87

Other composites
The main benefits of low-temperature 3D printing is its
capability to construct polymer/mineral composites with increased
beneficial material properties to include growth factors and drugs to
enhance bone regeneration or combat infection.89 Fused deposition
modeling has frequently used biomedical polymers with low melting
temperatures.90 Materials employed in fused deposition modeling to
produce porous scaffolds are polycaprolactone-bioactive glass (PCLBaG),91 L-lactide/e-caprolactone,91 polylactide-co-glycolide acid (PLGA)
with collagen infiltration,92 polycaprolactone-tricalcium phosphate
(PCL-TCP) with gentamicin,93 PCL-TCP,94 PLGA-TCP coated with HA,95
PCLPLGA-TCP,96 PLGA-PCL,97 and PCL coated with gelatin.98 The
mentioned composite materials have potential to be used in
applications like cartilage and bone tissue engineering,99 antibiotic
delivery systems,93 and for treatment of osseous craniofacial defects in
humans.94 A polymer (polypropylene)/ceramic (TCP) composite
scaffold with controlled porosity and various interior architectures has
been generated via the fused deposition modeling method. In vitro
test results indicated that these experimental scaffolds were non-toxic
and had good cell growth characteristics.100
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Sherwood et al have also produced osteochondral hybrid
composites in which the upper area was D, L-PLGA/L-PLA with 90%
porosity for cartilage regeneration, and the lower area was LPLGA/TCP
to enhance bone healing. The scaffold was developed employing the
combination of 3D printing and particulate leaching techniques.101
Other compositions including PCL/TCP or PCL/HA have been used with
fused deposition modeling because of their mechanical and biological
characteristics for bone healing.102
As another technique in 3D printing, selective laser sintering has
been known as a method feasible with medical data to make anatomyspecific constructions.90 In one study, polyvinyl alcohol/hydroxyapatite
(PVA/HA) composite was produced via the selective laser sintering
method, whereas HA particles were covered with PVA by the use of
spray-drying or physical blending. This material was introduced for
joints and craniofacial applications.103 A mandibular condyle scaffold
was fabricated using this technology by means of CT data from a pig
condyle.104 The combination of simulations and selective laser sintering
method facilitates the capability to formulate scaffolds with
anatomically shaped exterior architectures and porous internal
construction. The usual materials employed in selective laser sintering
are HA and PCL,105 β-TCP and PCL with collagen coating,106 Poly(3hydroxybutyrate-co-3-hydroxyvalerate)/Ca-P (PHBV/Ca-P), and polyL-lactide acid/calcium hydroxyapatite (PLLA/CHAp).107,108

Metals
Titanium
The amount of load sharing between the bone and implant
depends on the elastic modulus of the implant.109 Therefore, it is
important that the implant has similar mechanical behavior, especially
elastic modulus, to that of the natural bone.109 Potential biomaterials
for bone graft scaffolds, ceramics, and polymers have been widely
investigated; however, at times, they are not able to provide the
necessary mechanical requirements under the given loads.110,111
As a metallic biomaterial, titanium (Ti) has been extensively
employed in recent investigations due to its high corrosion resistance,
high strength/weight ratio, and confirmed biocompatibility.110,112 Ti has
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low density and suitable mechanical properties such as elastic
modulus, fatigue strength, and toughness.113 It has been extensively
employed for construction of implants, such as prosthetic joints,
trauma-locking plating systems, dental implants, screws, membranes,
and heart valves.109 Although the elastic modulus of bulk Ti is more
than that of natural bone, it is still less than other bio-metals such as
stainless steel or cobalt alloy.109 Table 1 summarizes the strength and
modulus of the natural jaw bone and several other bulk biomaterials
usually utilized as implants.109
Table 1. The strength and modulus of the natural jawbone and several bulk
biomaterials usually used as the implants. Adopted from work by Wiria et
al.109
Material

Strength (MPa)

Modulus (GPa)

Natural jaw bone

130 to 180

3 to 20

PLGA

2.82

2

Stainless steel 316L

170 to 750

200

Co-Cr-Mo

275 to 1585

200 to 230

Ti-6Al-4V

895 to 930

110 to 114

Commercially pure titanium

240 to 550

102 to 105

Alumina

400

350

Yttria-stabilized zirconia

900 to 1400

210

Several biomaterials have a strength and modulus greater than
bone (Table 1).109 It appears that pure Ti has a high potential to be
engineered so its modulus is close to that of bone.109 By introducing
porosity to bulk Ti to produce Ti scaffolds through engineering
approaches, its mechanical properties could be manipulated.
Moreover, the porosity provides the routes for the cells to grow inside
the porous implant.114 However, none of the conventional methods
have allowed for making porous materials with a desirable shape and
interconnected pores. To overcome the problems associated with
conventional methods, AM technology has been utilized.115 Until
recently, AM has mostly focused on polymer and ceramic
materials.116,117 Employing AM to metals for bone tissue engineering
has posed considerable challenges.113
Ryan et al110 used a commercial 3D printer (Thermojet) to
produce a porous Ti scaffold by a sacrificial wax template. Powder
metallurgy was employed to create porous Ti by filling the Ti slurry
around the wax template. The results of this research indicated that
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the porous Ti scaffolds with porosities of around 66.8% had
compression strength of 104.4 and 23.5 MPa in axial and transverse
directions, respectively, showing Ti's anisotropic properties. Cultured
osteoblast cells have also retained their metabolic activity on the
surface of Ti materials.110
Wiria et al109 also produced a porous Ti implant using 3D
printing with an elastic modulus of around 4.8 to 13.2 GPa and
compressive strength of 167 to 455 MPa. The elastic modulus of
fabricated porous Ti scaffolds was in the range of natural bone. The
cytocompatibility tests in this study showed that the produced Ti
scaffolds could provide a suitable surface for cells to live, proliferate,
and grow.109 Ti alloy (Ti6Al4V) was also used to produce scaffolds with
apt amounts of porosity, pore size, and interconnected pores. Li et
al113 developed 3D fiber deposition as an AM technique. The
experimental result of this study illustrated how the parameters
control the construction of porous scaffolds.113 In summary, Ti and Ti
alloy implants produced by 3D printing and tested by biomechanical
and in vitro investigations exhibit good mechanical properties and
biocompatibility, which confirm their potential use in tissue
engineering.109

Conclusion
Due to bone resorption, congenital defects, craniofacial defects,
trauma, and pathologies, lost tissue is often a difficult-to-treat issue.
During prosthodontic and dentoalveolar defect rehabilitation, it is
imperative that anatomical uniformity is maintained but also that
appearance and tissue function is reestablished.118 The gold standard
for management of such defects is autogenous grafts; however,
implanted scaffolds of varying materials have become a substitute. For
an ideal bioscaffold, certain characteristics need to be met, including
the provision of a 3D structure for the regeneration of natural tissues
and the ability to degrade in a steady manner and be replaced
completely by natural tissue.119 Such 3D scaffolds are customized and
manufactured using additive manufacturing methods. Several different
materials and their advantages and disadvantages (Tables 2 and 3)
have been investigated, including composites and metals as described
in this review. Currently one of the many challenges faced is to build a
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scaffold with optimal properties, while minimizing cost, toxicity, and
discomfort.
Table 2. Summary of bioceramic materials: advantages, disadvantages, and
potential materials used to construct composites
Bioceramics
Advantages

Tri-calcium phosphate
-Molding capability into
defects in granule form
-Osteoconductive

Hydroxyapatite
-Biocompatible
-Osteoconductive
-Non-immunogenic
-Mechanically stable

Disadvantages

Potential
materials for
making
composite

-Lack of macroporosity

-Expensive

-Must maintain low
sintering temperature

-Does not optimally
interact with liquid binder

-Collagen
-Hydroxyapatite

-Polyamide
-Chitosan

Bioglass
-Ability to support
osteoblast cells
-Bonding to soft and
hard tissues
-Angiogenesis
stimulation with VEGF
-Cytotoxicity with
surrounding
environment
-Polyethylene
-Poly (α-hydroxy acid)

Table 3. Summary of biopolymer materials: advantages, disadvantages, and
potential materials used to construct composite
Biopolymers

Alginate

Biogenic
polyphosphate

Biogenic silica

Advantages

-Inducing
chondrocyte
proliferation

-Osteocytes stimulation to -Biocompatible
undergo an anabolic
-Bioactive
process
-Regulator of scaffold
-Stimulator of
porosity
osteoblast
differentiation
-Osteoconductive

Disadvantages

-Mechanically
vulnerable

-Yet to be studied

-Not apparent

-Silicon
-Calcium

-Alginate

-Rapid degradability
Potential materials for
making composite

-Chitosan
-Polylactide

-Collagen
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